Ultrasound-Guided RSCTL vs EOIP Block for Analgesia in Sleeve Gastrectomy
Efficacy of Ultrasound-guided Retro Superior Costotransverse Ligament Space Block Versus External Oblique Intercostal Plane Block for Postoperative Analgesia in Laparoscopic Sleeve Gastrectomy: A Prospective Randomized Study
Beni-Suef University
90 participants
Feb 1, 2026
INTERVENTIONAL
Conditions
Summary
The aim of this study is to compare the effect of ultrasound-guided retro-SCTL space block and EOI block on opioid consumption within 24 hours after LSG.
Eligibility
Inclusion Criteria4
- Patients aged between 18 to 65 years
- Both genders
- American Society of Anesthesiologists (ASA) physical status I-II
- Body mass index (BMI) \> 40 kg m-2,
Exclusion Criteria9
- Obesity secondary to an endocrine disorder
- known allergic diathesis to any drugs used in the study
- Presence of serious systemic illness (e.g., severe cardiac, pulmonary, renal, or hepatic dysfunction),
- Coagulation dysfunction
- Pre-existing psychological disorders
- Current use of analgesic or psychotropic medications
- Infection at a potential injection site
- Ahistory of chronic pain
- Conversion to laparotomy.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants will receive ultrasound-guided Retro superior costotransverse ligament space block after intubation. Following hydrodissection with 2 ml of 0.9% saline to confirm the correct needle tip position, 20 ml 0.25% bupivacaine was injected. The same procedure was then repeated with 20 ml 0.25% bupivacaine on the contralateral side.
Participants will receive ultrasound-guided External Oblique Intercostal Plane Block after intubation.Following hydrodissection with 2 ml of 0.9% saline to confirm the correct needle tip position, 20 ml 0.25% bupivacaine was injected. The same procedure was then repeated with 20 ml 0.25% bupivacaine on the contralateral side.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07311525